Article Information
History
- May 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Michael P. Vincent1,
- Trevor Stack1,
- Amir Vahabikashi2,
- Guorong Li3,
- Kristin M. Perkumas3,
- Ruiyi Ren4,5,
- Haiyan Gong4,5,
- W. Daniel Stamer3,6,
- Mark Johnson1,7,8 and
- Evan A. Scott1,9,10,*
- 1Department of Biomedical Engineering, Northwestern University, Evanston, IL 60208, USA
- 2Department of Cell and Developmental Biology, Northwestern University, Northwestern University, Chicago, IL 60611, USA
- 3Department of Ophthalmology, Duke University, Durham, NC 27710, USA
- 4Department of Ophthalmology, Boston University School of Medicine, Boston, MA 02118, USA
- 5Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA 02118, USA
- 6Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
- 7Department of Ophthalmology, Northwestern University, Chicago, IL 60611, USA
- 8Department of Mechanical Engineering, Northwestern University, Evanston, IL 60208, USA
- 9Simpson Querrey Institute, Northwestern University, Chicago, IL 60611, USA
- 10Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA
- ↵*Corresponding Author E-mail: evan.scott{at}northwestern.edu.
Posted May 20, 2021.
Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
